Journey Medical (DERM) Other Working Capital Changes (2020 - 2026)
Journey Medical (DERM) posted Other Working Capital Changes of -$25000.0 for Q1 2026, down 8.7% on a QoQ basis from -$23000.0 in Q4 2025, and down 78.57% year-over-year from -$116666.7 in Q1 2025.
Journey Medical (DERM) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Journey Medical's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$25000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 78.57% year-over-year to -$25000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$93000.0 (down 8.14% YoY) and the FY2025 annual result came in at -$82000.0, up 14.58% from the prior year.
- Other Working Capital Changes was -$25000.0 for Q1 2026 at Journey Medical, down from -$23000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.7 million in Q4 2023 and bottomed at -$1.2 million in Q3 2024.
- A 5-year average of $27647.1 and a median of -$32000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes jumped 41.67% — and 2026, when it plunged 78.57%.
- Journey Medical's Other Working Capital Changes stood at -$22000.0 in 2022, then dropped by 4.55% to -$23000.0 in 2023, then increased by 4.35% to -$22000.0 in 2024, then dropped by 4.55% to -$23000.0 in 2025, then decreased by 8.7% to -$25000.0 in 2026.
- Business Quant data shows DERM's Other Working Capital Changes at -$25000.0 in Q1 2026, -$23000.0 in Q4 2025, and -$23000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | -841,000.00 |
| Sep 30, 2025 | -841,000.00 |
| Sep 30, 2025 | -841,000.00 |
| Jun 30, 2025 | 84,000.00 |
| Jun 30, 2025 | 84,000.00 |
| Jun 30, 2025 | 84,000.00 |
| Mar 31, 2025 | -817,000.00 |
| Mar 31, 2025 | -817,000.00 |
| Mar 31, 2025 | -817,000.00 |
| Dec 31, 2024 | 2.34 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | -1.16 Mn |
| Sep 30, 2024 | -1.16 Mn |